-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on RxSight, Maintains $13 Price Target

Benzinga·02/26/2026 12:23:26
Listen to the news
Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $13 price target.